000 04412nam a22004455i 4500
999 _c384300
_d384300
001 384300
003 ES-MaUEC
005 20230108105412.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 201013s2020 sz | s |||| 0|eng d
020 _a9783030412074
024 7 _a10.1007/978-3-030-41207-4
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.B8
_b2020 EB
245 0 0 _aBreast MRI for High-risk Screening
_cedited by Francesco Sardanelli, Franca Podo
250 _a1st edition 2020
264 1 _aCham
_bSpringer International Publishing
_c2020
300 _a1 recurso en línea (XXIII, 376 páginas)
_b84 ilustraciones, 32 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
505 0 _a Introduction -- Thirty years of contrast enhanced breast MRI -- The mantra about low specificity breast MRI -- BRCA and other genes conferring hereditary breast cancer predisposition -- Screening mammography: One size fits all? -- MRI protocols for breast cancer screening -- Contrast materials for screening MRI and concerns about tissue deposition -- Applying MRI BI-RADS in a high-risk population -- CAD systems for breast MRI screening -- Phenotype presentation and radiogenomics of breast cancer with special focus on high-risk women -- The body of primary evidence about MRI for high risk screening: retrospective and prospective studies -- High-risk screening: MRI alone? -- Secondary evidence from systematic reviews and meta-analyses -- Radioprotection issues for women with hereditary predisposition for breast cancer -- Impact of MRI screening on high-risk patient outcome -- The special case of previous chest radiation therapy -- IT infrastructure for data managing in multicenter high-risk screening -- Guidelines and recommendations all over the world: agreements and differences -- Medical options: Pharmacopreventio- Surgical options: Prophylactic mastectomy and oophorectomy -- Psychosocial aspects of high-risk of breast cancer -- Calculating, using and improving individual breast cancer risk estimates -- MRI for screening women with a personal history of breast cancer -- Screening MRI for the intermediate risk: an open issue -- Looking at the future: Personalized breast cancer screening -- Acknowledgments.
520 _aThis book offers a comprehensive overview of the use of breast MRI for screening high-risk women, including those with familial-genetic hereditary predisposition and previous chest radiation therapy, typically lymphoma survivors. It discusses the historical background of studies and research that provided the body of evidence in favor of MRI screening of these women. Technical and clinical topics are treated in dedicated chapters, including models for individualized risk estimation, radiogenomics of breast cancer in high-risk women, computer-aided detection/diagnosis and machine learning systems applied to breast MRI, and psycho-oncology issues. Alternatives to breast MRI screening such as pharmaco-prevention and prophylactic mastectomy are also discussed, taking into account the public debate on the "Angelina Jolie" effect. The high breast cancer risk model is proposed as a paradigm for personalized medicine. This book will be of interest to radiologists, surgeons, oncologists and to all professionals devoted to female healthcare.
988 _aSpringer_Medicine_2020
650 7 _2embne
_9142247
_aMamas
_xResonancia magnética nuclear (Medicina)
650 7 _2embne
_9423753
_aMamas
_xCáncer
_xDiagnóstico
650 7 _2embne
_9675316
_aMamas
_xDiagnóstico por imagen
700 1 _aSardanelli, Francesco
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aPodo, Franca
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030412067
776 0 8 _iPrinted edition:
_z9783030412081
776 0 8 _iPrinted edition:
_z9783030412098
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-41207-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2023
_dz
_esc
_zSI